Thank you for your interest in clinical research at National Jewish Health. Use the link below to search the studies we are offering and learn more information on those of particular interest to you. By participating in a clinical research study at National Jewish Health, you could help advance scientific discoveries that improve care for you or your loved ones.
What has been accomplished as a result of clinical research at National Jewish Health?
Many medications have been introduced to the marketplace as a direct result of the clinical trial work performed at National Jewish Health. These medications include Advair®, Claritin®, and Xolair® - medications used to treat allergies and asthma.
The Atopic Dermatitis Research Network (ADRN), sponsored by the National Institute of Allergy and Infectious Diseases, is a consortium of academic medical centers seeking to better understand why people with atopic dermatitis (AD) experience more skin infections. The consortium is currently conducting clinical research studies that focus on bacterial skin infections associated with AD, particularly Staphylococcus aureus infections.
More current research projects include working with people suffering from peanut allergies and evaluating monoclonal antibody therapies for treating allergic asthma. We are also testing new lung cancer screening diagnostics, enrolling for a cat allergy study, and seeking participants who have uncontrolled asthma.
There are many other laboratories and researchers at the main campus of National Jewish Health in Denver that conduct research on a variety of pulmonary health conditions.
How do I get involved in clinical research at National Jewish Health?
Your physician may know of current clinical research studies that are specific to your condition. You can also ask your doctor for more information if you’ve never talked about it before. You do not have to be a current patient of National Jewish Health in order to participate in a clinical research study.